Overview

SCIENTIFIC SCORE
Moderately Effective
Based on 16 Researches
8.2
USERS' SCORE
Good
Based on 13 Reviews
8.2
Supplement Facts
Serving Size: 1 Veg Capsule
Amount Per Serving
%DV
Curcumin Phytosome(Turmeric Rhizome Extract (curcuma longa)/Phosphatidyl Choline Complex) (Meriva® Turmeric Phytosome)(Standardized to min. 18% Curcuminoids - 90 mg)
500 mg
**

Top Medical Research Studies

9
Turmeric shows promise for NAFLD
In a recent clinical trial, we explored the effectiveness of Curcuma zedoaria Rosc., commonly known as turmeric, in treating non-alcoholic fatty liver disease (NAFLD). This condition is alarmingly widespread, affecting a significant portion of the global population. Over the course of 60 days, we compared turmeric with vitamin E, a standard treatment, to see which had better results.

Our study involved 68 patients with mild to moderate NAFLD, who were divided into two groups. One group received turmeric in capsule form, while the other took vitamin E. We looked at various outcomes, including improvements in liver function, symptoms like digestive issues and malaise, and ultrasound assessments of liver size.

The findings were compelling. We observed that turmeric outperformed vitamin E in alleviating subjective symptoms, such as discomfort in the upper right abdomen, and issues with appetite and digestion. Notably, there were no significant adverse effects reported with turmeric, making it a promising alternative for managing NAFLD.

Overall, our research highlights turmeric as a viable option for those seeking treatment for liver disease, offering benefits that may surpass those of conventional therapies.
Read More
9
Curcumin shows benefits for NAFLD
We explored the effects of phytosomal curcumin, a derivative of turmeric, on various physical health indicators in individuals with nonalcoholic fatty liver disease (NAFLD). This analysis sifted through multiple studies, particularly randomized controlled trials, to gauge how effective turmeric extracts might be in managing this condition.

The findings revealed that curcumin could significantly reduce body mass index (BMI), body fat percentage, weight, and waist circumference in participants compared to those who received a placebo. For instance, the average decrease in BMI was notable, with a mean difference of -0.72. These positive impacts suggest that incorporating turmeric can be beneficial for those struggling with weight-related challenges due to NAFLD.

However, curcumin did not show any significant effect on hip circumference or the waist-to-hip ratio, indicating that while there are benefits, not every measure of body composition will respond to treatment. Overall, we observed that phytosomal curcumin stands out as a promising ally in the fight against the complications associated with nonalcoholic fatty liver disease, primarily by improving key anthropometric indices.
Read More
9
Curcumin may help liver enzymes
Our analysis looked into how curcumin, derived from turmeric, might help those suffering from nonalcoholic fatty liver disease (NAFLD). We reviewed various randomized clinical trials, gathering data from multiple studies to assess its effects on liver enzymes, particularly alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP).

After examining 14 studies, we found promising results for ALT and AST, with curcumin treatment leading to significant reductions in their levels. Specifically, ALT decreased by an average of about 8.72 units, while AST dropped by around 6.35 units. This indicates that curcumin supplementation might indeed benefit liver health by lowering these critical enzyme levels.

On the other hand, when it came to ALP, the results weren't as clear-cut. Our pooled analysis showed no significant effect on ALP levels overall. However, further exploration revealed that patients who took curcumin for longer periods saw some benefits in their ALP readings.

In conclusion, our findings suggest that curcumin could play a useful role in managing liver health in individuals with NAFLD, particularly in reducing certain liver enzymes. However, we believe further studies are essential to fully understand these effects and offer clearer guidelines for supplementation.
Read More

Most Useful Reviews

9
Effective for liver inflammation
20 people found this helpful
I purchased this for my dog, who had liver inflammation. Despite curcumin's low bio-availability in turmeric form, giving him 1 gm/day for ten days lowered his ALT levels significantly. It shows great promise as an anti-inflammatory, and I appreciate the efforts of Indena, the manufacturer.
Read More
9
Antioxidant effects
Research reveals curcumin's antioxidant and anti-inflammatory benefits. It helps improve gut health, bile quality, and daily function for those with arthritis. Curcumin may also support cardiovascular health, manage type 2 diabetes, and enhance cognitive functions while preventing age-related decline.
Read More
9
Liver health support
This is my primary supplement for maintaining good liver health. I recommend Meriva as the ideal form to use.
Read More

Medical Researches

SCIENTIFIC SCORE
Moderately Effective
Based on 16 Researches
8.2
  • All Researches
9.5
Curcumin shows promise in liver treatment
We explored the use of curcumin, a compound found in turmeric, in treating acute liver injury (ALI). To enhance curcumin's effectiveness, we created a specialized delivery system using human serum albumin (HSA) that releases curcumin in response to reactive oxygen species (ROS), which are often elevated during inflammation. This system was then cloaked with macrophage membranes to improve targeting to inflamed liver tissues.

Our results showed that this innovative approach allowed the curcumin to be effectively delivered to the injured liver, where it significantly reduced ROS levels and the production of pro-inflammatory cytokines. This suggests that curcumin can help alleviate inflammation during ALI by shifting the balance of immune responses.

We found that the delivery system helped protect liver cells from oxidative stress and promoted a shift in the immune response, which is a vital part of recovery from liver injury. Overall, we observed promising outcomes that position this curcumin delivery method as a potential therapy for managing acute liver injury.
Read More
9
Curcumin shows benefits for NAFLD
We explored the effects of phytosomal curcumin, a derivative of turmeric, on various physical health indicators in individuals with nonalcoholic fatty liver disease (NAFLD). This analysis sifted through multiple studies, particularly randomized controlled trials, to gauge how effective turmeric extracts might be in managing this condition.

The findings revealed that curcumin could significantly reduce body mass index (BMI), body fat percentage, weight, and waist circumference in participants compared to those who received a placebo. For instance, the average decrease in BMI was notable, with a mean difference of -0.72. These positive impacts suggest that incorporating turmeric can be beneficial for those struggling with weight-related challenges due to NAFLD.

However, curcumin did not show any significant effect on hip circumference or the waist-to-hip ratio, indicating that while there are benefits, not every measure of body composition will respond to treatment. Overall, we observed that phytosomal curcumin stands out as a promising ally in the fight against the complications associated with nonalcoholic fatty liver disease, primarily by improving key anthropometric indices.
Read More
9
Tetrahydrocurcumin aids liver health
We explored the effects of Tetrahydrocurcumin (THC), a compound derived from turmeric, on liver disease, specifically focusing on metabolic dysfunction-associated steatohepatitis (MASH). The study involved C57BL/6 mice that were subjected to a methionine-choline-deficient diet for eight weeks to induce MASH. We administered THC to one group of mice while another group received obeticholic acid as a positive control.

After treatment, we observed several promising outcomes. THC significantly reduced oxidative stress and fat accumulation in liver cells, lessened liver injury, and improved overall liver health in the mice. It also corrected 34 different lipid imbalances brought on by the diet, enhancing the diversity and abundance of beneficial gut bacteria while lowering harmful strains linked to obesity.

Additionally, bile acid analysis showed THC decreased the levels of certain toxic bile acids in the serum that can harm the liver. Importantly, THC also influenced gene expression related to fat production and bile acid secretion, indicating a multifaceted approach to combating liver issues. Overall, this research suggests that THC may be a valuable compound in promoting liver health and offers insights for future treatments targeting MASH.
Read More
9
Turmeric shows promise for NAFLD
In a recent clinical trial, we explored the effectiveness of Curcuma zedoaria Rosc., commonly known as turmeric, in treating non-alcoholic fatty liver disease (NAFLD). This condition is alarmingly widespread, affecting a significant portion of the global population. Over the course of 60 days, we compared turmeric with vitamin E, a standard treatment, to see which had better results.

Our study involved 68 patients with mild to moderate NAFLD, who were divided into two groups. One group received turmeric in capsule form, while the other took vitamin E. We looked at various outcomes, including improvements in liver function, symptoms like digestive issues and malaise, and ultrasound assessments of liver size.

The findings were compelling. We observed that turmeric outperformed vitamin E in alleviating subjective symptoms, such as discomfort in the upper right abdomen, and issues with appetite and digestion. Notably, there were no significant adverse effects reported with turmeric, making it a promising alternative for managing NAFLD.

Overall, our research highlights turmeric as a viable option for those seeking treatment for liver disease, offering benefits that may surpass those of conventional therapies.
Read More
9
Metal-enriched curcumin targets liver fibrosis
We investigated a promising approach to tackle liver fibrosis, a serious condition linked to chronic liver diseases. Our focus was on curcumin, a compound found in turmeric, and its ability to be effectively delivered to the liver using innovative nanocarriers.

Our study utilized a specially designed delivery system that paired curcumin with a metal-based substance known as Cu-coordinated mesoporous polydopamine (CMP). This combination not only aimed to harness the antifibrotic properties of curcumin but also to address the buildup of harmful reactive oxygen species (ROS) that contribute to liver damage.

We found that the CMP carried curcumin efficiently while improving its antioxidant abilities, leading to better cellular uptake. Importantly, tests showed that this nanodrug significantly reduced the proliferation of liver cells that lead to fibrosis and effectively scavenged harmful ROS without harmful effects on healthy cells.

In vivo studies demonstrated that the combination of curcumin and CMP reduced collagen deposits, alleviating liver fibrosis while maintaining safety. This highlights the potential of using turmeric-derived curcumin in targeted treatments for liver diseases, paving the way for better therapeutic strategies.
Read More

User Reviews

USERS' SCORE
Good
Based on 13 Reviews
8.2
  • All Reviews
  • Positive Reviews
  • Negative Reviews
9
Effective for liver inflammation
20 people found this helpful
I purchased this for my dog, who had liver inflammation. Despite curcumin's low bio-availability in turmeric form, giving him 1 gm/day for ten days lowered his ALT levels significantly. It shows great promise as an anti-inflammatory, and I appreciate the efforts of Indena, the manufacturer.
Read More
9
Antioxidant effects
Research reveals curcumin's antioxidant and anti-inflammatory benefits. It helps improve gut health, bile quality, and daily function for those with arthritis. Curcumin may also support cardiovascular health, manage type 2 diabetes, and enhance cognitive functions while preventing age-related decline.
Read More
9
Liver health support
This is my primary supplement for maintaining good liver health. I recommend Meriva as the ideal form to use.
Read More
7.5
Pain relief observed
25 people found this helpful
Curcumin effectively alleviates my pain without harming my liver, unlike other NSAIDs. I can use it long-term, and my liver panel improved as a result. It inhibits iron absorption, which is useful given my low haemoglobin levels. My doctor confirmed it acts as an iron chelator, but isn’t severe enough to cause anaemia. I now take it after meals, which does not affect my sleep. Ran out of curcumin phytosome and noticed the pain return. I highly recommend it.
Read More
7.5
Bioavailable curcumin benefit
15 people found this helpful
I prefer this curcumin due to its enhanced bioavailability, which is evident through practice. It reduces inflammation, alleviates joint and muscle pains, and aids in recovery during colds. I take 1-2 capsules daily with Lecithin and even use the powder in cosmetic masks. The natural ingredients are excellent, and I recommend this product.
Read More

Frequently Asked Questions

7.5
Better liver function
I'm taking this out of concern for my liver function. After six months, my liver disease markers in health check-ups have improved, so I will continue using it.
7.5
Improved brain energy
Taking this supplement with lecithin enhances my brain energy. It effectively alleviates hangover symptoms and offers protection against liver disease.
9
Effective for liver inflammation
20 people found this helpful
I purchased this for my dog, who had liver inflammation. Despite curcumin's low bio-availability in turmeric form, giving him 1 gm/day for ten days lowered his ALT levels significantly. It shows great promise as an anti-inflammatory, and I appreciate the efforts of Indena, the manufacturer.
7.5
Pain relief observed
25 people found this helpful
Curcumin effectively alleviates my pain without harming my liver, unlike other NSAIDs. I can use it long-term, and my liver panel improved as a result. It inhibits iron absorption, which is useful given my low haemoglobin levels. My doctor confirmed it acts as an iron chelator, but isn’t severe enough to cause anaemia. I now take it after meals, which does not affect my sleep. Ran out of curcumin phytosome and noticed the pain return. I highly recommend it.
7.5
Liver protection noted
Curcumin demonstrates anti-inflammatory properties and is beneficial for chronic inflammatory conditions like ulcerative colitis. It alleviates joint pain, enhances function, and has shown antitumour effects. It has been studied for its potential against certain cancers and even has antibacterial and antidepressant properties. It's a remarkable supplement for health.
7.5
Quality ingredients
I consistently take curcumin with a liver protectant, and I am satisfied with the quality and ingredients. It effectively supports liver health.
7.5
Aches alleviated
This product is helpful for minor aches and pains and contributes positively to liver health. Be sure to choose Curcumin Phytosome for optimal absorption, unlike standard options available in shops.
9
Curcumin may help liver enzymes
Our analysis looked into how curcumin, derived from turmeric, might help those suffering from nonalcoholic fatty liver disease (NAFLD). We reviewed various randomized clinical trials, gathering data from multiple studies to assess its effects on liver enzymes, particularly alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP).

After examining 14 studies, we found promising results for ALT and AST, with curcumin treatment leading to significant reductions in their levels. Specifically, ALT decreased by an average of about 8.72 units, while AST dropped by around 6.35 units. This indicates that curcumin supplementation might indeed benefit liver health by lowering these critical enzyme levels.

On the other hand, when it came to ALP, the results weren't as clear-cut. Our pooled analysis showed no significant effect on ALP levels overall. However, further exploration revealed that patients who took curcumin for longer periods saw some benefits in their ALP readings.

In conclusion, our findings suggest that curcumin could play a useful role in managing liver health in individuals with NAFLD, particularly in reducing certain liver enzymes. However, we believe further studies are essential to fully understand these effects and offer clearer guidelines for supplementation.
9
Curcumin improves liver health outcomes
We sought to understand the effectiveness of turmeric, particularly its active component curcumin, in treating metabolic-associated steatotic liver disease (MASLD). Through a systematic review and meta-analysis of randomized controlled trials (RCTs), we examined data from 27 studies that included 1691 participants.

Our findings showed that curcumin has a significant positive effect on reducing liver fat content. Specifically, it improved hepatic steatosis by more than four times compared to a placebo group. Resveratrol, another natural polyphenol we studied, also indicated benefits, improving liver fat levels but not to the same extent as curcumin.

We also looked at liver enzyme levels, where silymarin emerged as the top contender for reducing ALT levels—the enzyme often elevated in liver diseases. Curcumin did well in this area too, showing a notable decrease in ALT and AST levels, signaling healthier liver function. Alongside liver benefits, curcumin improved metabolic factors like blood glucose and body mass index.

Overall, while curcumin stood out as particularly effective for liver health, silymarin showed impressive results in liver enzyme reduction, and resveratrol offered some benefits for metabolic enhancements. Together, these polyphenols present appealing options for complementing traditional treatments for liver disease.
3
Curcumin's variable effects on HBV
We examined how curcumin, a natural compound found in turmeric, influences the hepatitis B virus (HBV) in liver cells. The research focused on two different liver cell lines, HepG22.15 and Huh7, to determine whether curcumin has a positive effect on HBV replication.

Our findings revealed a strikingly different response between the two cell lines. In HepG22.15 cells, curcumin didn’t seem to affect the levels of viral DNA or some RNA forms, but it did lower specific antigen levels. In contrast, Huh7 cells responded to curcumin with a significant increase in HBV replication and higher levels of viral antigens and RNAs.

Additionally, we looked at how curcumin affected cellular processes. In Huh7 cells, we observed that curcumin triggered cell cycle changes, particularly causing an arrest at a specific phase, which might create an environment favorable for viral replication. However, no such changes occurred in HepG22.15 cells. Overall, this variability raises questions about the consistent effectiveness of curcumin for liver disease treatment, making its role somewhat controversial.
8
Turmeric shows promise for liver health
We examined a body of research focused on the effects of turmeric, specifically its active component curcumin, on liver disease, particularly metabolic dysfunction-associated steatotic liver disease (MASLD). The analysis drew from numerous studies that included randomized controlled trials and systematic reviews covering the period from 2000 to 2023.

Our findings revealed that turmeric, through its active curcumin, has been one of the most studied bioactive substances in relation to liver health. Out of the total research, 25 studies were specifically dedicated to curcumin's effects. This suggests a significant interest in its potential benefits for those suffering from liver conditions.

However, we also noted substantial variation in how the studies measured their outcomes. Most commonly, researchers reported on aspects like liver health, body weight, and blood lipid levels, but there remains a crucial need for more uniformity and clarity in how results are interpreted. Despite promising trends, definitive conclusions on curcumin's effectiveness still require further investigation and synthesis of existing findings to establish clear clinical guidelines.

Overall, while there is a wealth of information suggesting turmeric may help, it is important to dive deeper into this research to confirm its benefits for liver disease and understand the nuances that come with it.

References

  1. Petagine L, Zariwala MG, Somavarapu S, Chan SHY, Kaya EA, et al. Oxidative stress in a cellular model of alcohol-related liver disease: protection using curcumin nanoformulations. Sci Rep. 2025;15:7752. doi:10.1038/s41598-025-91139-0
  2. Elizalde MM, Fuentes P, Chiappetta D, Flichman DM. Contrasting Effect of Curcumin on Hepatitis B Virus Replication According to the Hepatoma Cell Line. Pathogens. 2025;14. doi:10.3390/pathogens14020203
  3. Liu N, Li H. Influence of phytosomal curcumin on anthropometric indices for nonalcoholic fatty liver disease: A meta-analysis. Medicine (Baltimore). 2024;103:e40538. doi:10.1097/MD.0000000000040538
  4. Hamouda MAB, Saad AH, El-Saadany AAEAE, El Sharawey TMHA, Abdo W, et al. Trials for reducing the dangerous effect on poultry fed on aflatoxin contaminated ration using nano curcumin. BMC Vet Res. 2025;21:72. doi:10.1186/s12917-025-04519-z
  5. Hemati S, Mehrabinejad F, Elhaie M, Najafizade N. Curcumin Supplementation as a Preventive Strategy Against Tamoxifen-Induced Nonalcoholic Fatty Liver Disease in ER+ Breast Cancer Patients: A Triple-Blind Randomized Placebo-Controlled Trial. J Diet Suppl. 2025;22:274. doi:10.1080/19390211.2025.2465412
  6. Peng S, Meng M, Luo P, Liu J, Wang J, et al. Tetrahydrocurcumin Alleviates Metabolic Dysfunction-Associated Steatohepatitis in Mice by Regulating Serum Lipids, Bile Acids, and Gut Microbiota. Int J Mol Sci. 2025;26. doi:10.3390/ijms26030895
  7. Handu D, Stote K, Piemonte T. Evaluating Bioactive-Substance-Based Interventions for Adults with MASLD: Results from a Systematic Scoping Review. Nutrients. 2025;17. doi:10.3390/nu17030453
  8. Feng JN, Shao W, Yang L, Pang J, Ling W, et al. Hepatic fibroblast growth factor 21 is required for curcumin or resveratrol in exerting their metabolic beneficial effect in male mice. Nutr Diabetes. 2025;15:4. doi:10.1038/s41387-025-00363-0
  9. Ashraf A, Rather SA, Mehraj M. "Evaluation of Curcuma zedoaria Rosc. in the management of non-alcoholic fatty liver Disease: A Randomized, single blind, controlled trial". Arab J Gastroenterol. 2025;26:112. doi:10.1016/j.ajg.2025.01.004
  10. Liu X, Mu X, Wang Y, Liu Z, Li Y, et al. Metal-based mesoporous polydopamine with dual enzyme-like activity as biomimetic nanodrug for alleviating liver fibrosis. J Colloid Interface Sci. 2025;684:586. doi:10.1016/j.jcis.2025.01.081
  11. Ebrahimzadeh A, Ebrahimzadeh A, Fooladshekan S, Mohseni S, Mohtashamian A, et al. Therapeutic effects of curcumin supplementation on liver enzymes of nonalcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials. Food Sci Nutr. 2025;13:e4144. doi:10.1002/fsn3.4144
  12. Hu D, Huang Z, Li W, Shan L, Wu MY, et al. Macrophage Membrane-Cloaked ROS-Responsive Albumin Nanoplatforms for Targeted Delivery of Curcumin to Alleviate Acute Liver Injury. Mol Pharm. 2025;22:771. doi:10.1021/acs.molpharmaceut.4c00808
  13. Lee SO, Chu KB, Yoon KW, Heo SI, Song JH, et al. Combinatorial Treatment with Praziquantel and Curcumin Reduces Parasite Burden and Clonorchiasis-Associated Pathologies in Rats. Pharmaceutics. 2024;16. doi:10.3390/pharmaceutics16121550
  14. Huang Q, An Z, Xin X, Gou X, Tian X, et al. The Effectiveness of Curcumin, Resveratrol, and Silymarin on MASLD: A Systematic Review and Meta-Analysis. Food Sci Nutr. 2024;12:10010. doi:10.1002/fsn3.4595
  15. Ranneh Y, Bedir AS, Abu-Elsaoud AM, Al Raish S. Polyphenol Intervention Ameliorates Non-Alcoholic Fatty Liver Disease: An Updated Comprehensive Systematic Review. Nutrients. 2024;16. doi:10.3390/nu16234150
  16. Wu Y, Guo F, Ma Y, Chai W, Li J, et al. Curcumin's Protective Role in Heatstroke-Induced Acute Liver Injury: Targeting Pyroptosis and Enhancing SIRT1 Expression. Glob Chall. 2024;8:2400178. doi:10.1002/gch2.202400178
image